Name | Number of supported studies | Average coverage | |
---|---|---|---|
GABAergic neuron | 3 studies | 33% ± 2% | |
astrocyte | 3 studies | 33% ± 10% | |
glutamatergic neuron | 3 studies | 42% ± 9% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 34% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 98% | 145.05 | 2579 / 2642 | 38% | 0.69 | 271 / 705 |
lung | 100% | 328.75 | 576 / 578 | 25% | 0.81 | 291 / 1155 |
prostate | 98% | 115.38 | 241 / 245 | 24% | 0.74 | 121 / 502 |
uterus | 98% | 102.31 | 167 / 170 | 18% | 0.49 | 82 / 459 |
ovary | 99% | 148.74 | 179 / 180 | 10% | 0.20 | 43 / 430 |
breast | 99% | 106.62 | 455 / 459 | 10% | 0.29 | 111 / 1118 |
thymus | 100% | 241.96 | 651 / 653 | 8% | 0.21 | 50 / 605 |
kidney | 100% | 180.27 | 89 / 89 | 8% | 0.15 | 69 / 901 |
pancreas | 98% | 174.11 | 323 / 328 | 6% | 0.11 | 10 / 178 |
adipose | 99% | 121.26 | 1193 / 1204 | 0% | 0 | 0 / 0 |
esophagus | 79% | 67.33 | 1146 / 1445 | 13% | 0.37 | 24 / 183 |
skin | 78% | 63.10 | 1415 / 1809 | 14% | 0.42 | 67 / 472 |
heart | 92% | 86.64 | 794 / 861 | 0% | 0 | 0 / 0 |
bladder | 86% | 67.38 | 18 / 21 | 6% | 0.16 | 31 / 504 |
adrenal gland | 82% | 50.62 | 212 / 258 | 6% | 0.09 | 13 / 230 |
intestine | 84% | 60.77 | 815 / 966 | 3% | 0.08 | 18 / 527 |
stomach | 80% | 48.97 | 287 / 359 | 8% | 0.14 | 22 / 286 |
blood vessel | 84% | 54.09 | 1127 / 1335 | 0% | 0 | 0 / 0 |
spleen | 69% | 40.22 | 167 / 241 | 0% | 0 | 0 / 0 |
muscle | 56% | 24.40 | 453 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 27% | 39.73 | 254 / 929 | 0% | 0 | 0 / 0 |
liver | 17% | 5.58 | 38 / 226 | 3% | 0.05 | 11 / 406 |
tonsil | 0% | 0 | 0 / 0 | 9% | 0.35 | 4 / 45 |
eye | 0% | 0 | 0 / 0 | 6% | 0.13 | 5 / 80 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.14 | 1 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0000080 | Biological process | mitotic G1 phase |
GO_0140013 | Biological process | meiotic nuclear division |
GO_0043069 | Biological process | negative regulation of programmed cell death |
GO_0000800 | Cellular component | lateral element |
GO_0000779 | Cellular component | condensed chromosome, centromeric region |
GO_0005654 | Cellular component | nucleoplasm |
GO_0001674 | Cellular component | female germ cell nucleus |
Gene name | SYCP2L |
Protein name | Synaptonemal complex protein 2-like (SCP-2-like) (145 kDa nucleolar protein homolog) (hsNO145) Synaptonemal complex protein 2 like |
Synonyms | NO145 C6orf177 |
Description | FUNCTION: Oocyte-specific protein that localizes to centromeres at the dictyate stage and regulates the survival of primordial oocytes. . |
Accessions | ENST00000487561.2 ENST00000341041.8 [Q5T4T6-2] Q5T4T6 ENST00000283141.11 [Q5T4T6-1] H7C4Q1 |